ESR1 and breast cancer: By fusing double ERE and double PRE, we formed an ER/PR response element that can efficiently detect both proteins in breast cancer cells, activating the expression of iRFP713 and allowing cancer cells to display red light under near-infrared laser (Figs. 4, 6).